MST-0312
/ Mestag Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
MST-0312: Targeted LTBR agonist designed to induce tertiary lymphoid structures (TLS) and high endothelial venules (HEV) for the treatment of solid tumors
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1